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Background: We have developed crosslinked salmon-derived atelocollagen sponge, which has a denaturation
temperature of 47 degrees Celsius. The purpose of this study is to evaluate the fundamental in vivo efficacy of the
osteogenic protein (OP) -1 containing salmon-derived collagen sponge disc (SCS) on cartilage regeneration, using a
rabbit model.
Methods: A total of 24 rabbits were used in this study. In each animal, a full-thickness osteochondral defect was
created in each femoral trochlea. Then, each 12 rabbits were randomly divided into the two groups. In Group I, an
OP1-SCS disc was implanted into the defect in the right knee. In Group II, a SCS disc without OP-1 was implanted
into the defect in the right knee. A control group of 12 rabbits was assembled from randomly-selected left knees
from among the first two groups. In Group-III, we applied no treatment for a defect in the left knee to obtain the
untreated control. All rabbits were sacrificed at 12 weeks after surgery. In each group, 10 animals were used for
histological and immunohistological evaluations, and the remaining 2 were used for real-time polymerase chain
reaction (PCR) analyses.
Results: In Group I, a regenerated cartilage tissue rich in proteoglycan and type-2 collagen was found at 12 weeks,
although the width was thicker than that of Group II. In Group II, the defect was filled with thick inhomogeneous
tissues, including cartilage, fibrous, and bone tissues at 12 weeks. Concerning the gross observation and histological
scores at 12 weeks, the ANOVA showed significant differences (p < 0.0001, and p < 0.0001, respectively). The post-
hoc test indicated that the gross observation and histological scores of Group I was significantly greater than those
of Groups II (p = 0.035, and p = 0.0104, respectively) and III (p < 0.0001, and p < 0.0001, respectively), while Group II
was significantly greater than Group III (p = 0.0069, and p = 0.005, respectively). The real time PCR analysis showed
that gene expression of type-2 collagen and aggrecan of Group I was greater than that of Group II.
Conclusions: The present study clearly demonstrated that the implantation of the OP1-SCS disc without any
cultured cells may induce spontaneous hyaline-like cartilage regeneration to greater degrees than implantation of
only the salmon-derived collagen sponge disc.
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Functional repair of an articular osteochondral defect
remains a major challenge in orthopaedic surgery [1-4].
Bovine and porcine atelocollagen materials have com-
monly been used as useful scaffolds. Mammalian-derived
atelocollagens, however, carry potential risks of disease
(zoonosis) transmission, such as bovine spongiform
encephalopathy (BSE), foot-and-mouth disease, and so
on, to humans [5]. On the other hand, fish-derived
atelocollagen is known to be safe for human beings
concerning the zoonosis transmission [6]. In addition,
fish atelocollagen has a potentially large pool source with
a low cost [5]. Therefore, fish atelocollagen has a poten-
tial that can be an alternative to animal collagen. Fish-
derived atelocollagen, however, has not yet been used as
a medical biomaterial because of its low denaturation
temperature [7]. Namely, fish-derived atelocollagen is
transformed into gelatin at a human body temperature.
Recently, however, we have developed a cross-linked
salmon-derived atelocollagen, which is not transformed
into gelatin even at a human body temperature [8,9].
Our recent in vitro studies have shown that the cross-
linked salmon-derived atelocollagen has a better ability
concerning cell proliferation in the surface culture than
commonly used swine-derived atelocollagen [10,11].
Therefore, we have studied to develop a cell-free device
for cartilage repair, which can be implanted without cell
culture into an osteochondral defect. In our preliminary
in vivo study using rabbits, implantation of the salmon-
derived cross-linked atelocollagen into an osteochondral
defect induced hyaline-like cartilage regeneration in the
defect, while the commonly available porcine collagen
does not have such effects [12]. However, the inductive
ability of hyaline-like cartilage regeneration is not suffi-
cient because the width of the regenerated cartilage
tissue was approximately a half of the normal articular
cartilage width. A possible solution to this issue is to
create a composite collagen material containing some
signaling molecules, which can enhance the cartilageA.
Figure 1 A salmon-derived cross-linked atelocollagen sponge disc co
cartilage repair (A) and the ultrastructure of the atelocollagen spongeregeneration ability of salmon-derived cross-linked
atelocollagen. We have focused on osteogenic protein
(OP)-1, which is also called bone morphogenetic
protein-7 (BMP-7). OP-1 is known as a potent signaling
molecule, which has been clinically applied for bone and
cartilage repair [13], because they are produced en-
dogenously by human adult articular chondrocytes and
are able to stimulate the synthesis of cartilage extracellu-
lar matrix components [14-16]. In addition, OP-1 is
shown to exhibit not only pro-anabolic but also
anticatabolic activities for cartilageous tissues [17]. Thus,
we have developed a salmon-derived cross-linked
atelocollagen sponge disc containing OP-1 as a novel
cell-free device for cartilage repair (Figure 1).
The purpose of this study is to evaluate the fundamental
in vivo efficacy of the OP-1 containing salmon-derived
collagen sponge disc (abbreviated as “OP1-SCS disc”) on
cartilage regeneration, using a rabbit model. Specific
hypotheses in this study include, first, that the OP1-SCS
disc may not show any detrimental effects in the knee
joint, when they were implanted into an osteochondral de-
fect created in the rabbit knee. The second hypothesis is
that the implanted OP1-SCS disc may be completely
absorbed at 12 weeks. The third hypothesis is that the
implantation of the OP1-SCS disc without any cultured
cells may induce spontaneous hyaline-like cartilage regen-
eration to greater degrees than implantation of only the
salmon-derived collagen sponge disc.
Methods
Preparation of the salmon-derived collagen sponge disc
containing OP-1
The crosslinked atelocollagen sponge disc was prepared
from the fresh skin of chum salmon by acid solubilization
and subsequent pepsin digestion, according to a procedure
previously reported [6]. Briefly, the lyophilized salmon-
derived collagen was added to 100 mL of diluted HCl
(pH 3) to a concentration of 0.5% (w/v) and stirred over-
night at 4 degrees Celsius. Next, 1 ml of the collagenB.
ntaining OP-1 (OP-1SCS disc) as a novel cell-free device for
(B).
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for tissue culture (Asahi Techno Glass, Tokyo, Japan)
and then frozen at −70 degrees Celsius for 12 hours.
The frozen plates were placed into a lyophilizer (FDU-830,
Tokyo Rikakikai, Tokyo, Japan) for 24 hours. The obtained
porous materials were immersed in a 4-M NaCl aqueous
solution containing 1% (w/v) water-soluble EDC (Dojindo,
Tokyo, Japan) and kept at 4 degrees Celsius for 24 hours.
These materials were washed three times with diluted
water and then lyophilized again. Thus, we obtained
the crosslinked atelocollagen sponge. The degree of
crosslinking (the decrease ratio in the free amine group
contents of the crosslinked sample to the uncrosslinked
sample) of this collagen sponge was approximately 40%
[12]. Our previous in vivo study [12] showed that the
crosslinked SCS sponge did not show any detrimental
effects in the knee joint, when they were implanted into
an osteochondral defect created in the rabbit knee. From
this material, we created the OP1-SCS disc for implant-
ation in the present study (Figure 1). Each disc had a
diameter of 4.5 mm and a height of 3 mm. We injected
10-μg OP-1 (R&D Systems, Minneapolis, MN, USA)
dissolved in 1-ml saline solution into a core portion of the
disc immediately before implantation. This dose of OP-1
was chosen based on a previous study [18].
Study design and animal experimentation
Animal experiments were carried out in the Institute of
Animal Experimentation, Hokkaido University School of
Medicine under the Rules and Regulation of the Animal
Care and Use Committee. A total of 24 mature female
Japanese white rabbits, weighing 3.9 ± 0.5 kg, were used
in this study. An operation for each animal was
performed under intravenous anesthesia (pentobarbital,
25 mg/kg) under sterile conditions. In each animal, the
bilateral knee joints were exposed through a medial
parapatellar incision, and the patella was dislocated
laterally. A full-thickness osteochondral defect having a
diameter of 4.3 mm and a depth of 3 mm was created in
each femoral trochlea, using a sharp drill. Then, in 12 of
the 24 rabbits, we implanted an OP1-SCS disc into the
defect in the right knee (Group-I knees) using the press-
fit technique. In the remaining 12 rabbits, we implanted
a salmon-derived collagen sponge disc without OP-1
into the defect in the right knee (Group-II knees) in the
same manner. In each group, we applied no treatment
for a defect in the left knee to obtain the untreated
control (Group-III knees). The incised joint capsule and
the skin wound were closed in layers with 3–0 nylon
sutures, and an antiseptic spray dressing was applied.
Postoperatively, each animal was allowed unrestricted
activity in a cage (310 × 550 × 320 mm) without any
joint immobilization. All rabbits were sacrificed at
12 weeks after surgery. This period was chosen becauseit was considered to be the best period to compare the
degree of cartilage regeneration among the 3 groups
according to the previous study [12]. The knee joints
were immediately removed en bloc with the surrounding
tissue. In each group, 10 animals were used for histo-
logical and immunohistological evaluations, and the
remaining 2 were used for real-time polymerase chain
reaction (PCR) analyses.
Gross observations and histological evaluations
At the time of sacrifice, the tissue regenerated in the
osteochondral defect underwent gross observations, and
was quantitatively evaluated with the grading scale
reported by Wayne et al. [19]. The maximum total score
was 16 points. A distal portion of the resected femur was
fixed in a 10% neutral buffered formalin solution for
3 days, decalcified with 50 mM ethylenediaminetetraacetic
acid for a period of 3–4 weeks, and then cast in a paraffin
block. The femur was sectioned perpendicular to the lon-
gitudinal axis, and stained with Hematoxylin-Eosin and
Safranin-O. For immuno-histological evaluations, mono-
clonal antibody (anti-hCL(II), purified IgG, Fuji Chemical
Industries Ltd, Toyama, Japan) was used as primary anti-
bodies. Immunostaining was carried out according to the
manufacturer’s instructions using the Envision immuno-
staining system (DAKO Japan, Kyoto, Japan). Finally, the
sections were counterstained with hematoxylin. Histology
was evaluated with a scoring system reported by Wayne
et al. [19]. Subsequently, the maximum total score was 19
points. In addition, for each defect, randomly selected 3
sections of central portion with Safranin-O were evaluated
by 2 authors (E.K., Y.K.) under a blinded manner. Cellular-
ity of the nuclei in the proteoglycan-rich tissue were ob-
served with light microscopy.
Real-time PCR analysis
Total RNA was extracted from the tissues regenerated
in the defect using the RNeasy mini kit (Qiagen Inc.,
Valencia, CA) at 12 weeks. RNA quality from each sam-
ple was assured by the A260/280 absorbance ratio. The
RNA (100 ng) was reverse-transcribed into single strand
cDNA using PrimeScriptW RT reagent Kit (TakaraBio,
Ohtsu, Japan). The RT reaction was carried out for
15 min at 37 degrees Celsius and then for 5 sec at 85 de-
grees Celsius. All oligonucleotide primer sets were
designed based upon the published mRNA sequence.
The expected amplicon lengths ranged from 93 to
189 bp. The sequences of primers used in real time PCR
analyses for rabbit regenerative tissues were as follows:
type 2 collagen forward GACCATCAATGGCGGCTTC;
reverse CACGCTGTTCTTGCAGTGGTAG. Aggrecan
forward GCTACGACGCCATCTGCTAC; reverse GTCTG
GACCGTGATGTCCTC. SOX9 forward AACGCCGAGC
TCAGCAAGA; reverse TGGTACTTGTAGTCCGGGTG
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TGAA; reverse AGGCCATGTGGACCATGAG. The real-
time PCR was performed in Thermal Cycler DiceW TP800
(TakaraBio, Ohtsu, Japan) by using SYBRW Premix Ex
TaqTM (TakaraBio, Ohtsu, Japan). cDNA template
(5 ng) was used for real-time PCR in a final volume of
25 microliters. cDNA was amplified according to the
following conditions: 95 degrees Celsius for 5 sec and
60 degrees Celsius for 30 sec at 40 amplification cycles.
Fluorescene changes were monitored with SYBR Green
after every cycle. A dissociation curve analysis was
performed (0.5 degrees Celsius /sec increase from 60 to 95
degrees Celsius with continuous fluorescene readings) at
the end of cycles to ensure that single PCR products were
obtained. The amplicon size and reaction specificity were
confirmed by 2.5% agarose gel electrophoresis. The results
were evaluated using the Thermal Cycler DiceW Real Time
System software program (TakaraBio, Ohtsu, Japan).
Glyceroaldehyde-3-phosphate dehydrogenase (GAPDH)
primers were used to normalize samples.
Statistical analysis
A priori power analysis was performed. A sample size
was calculated to have 70% to 83% power to test the hy-
pothesis. All data were described as the mean and
standard deviation values. The one-way analysis of vari-
ance (ANOVA) was performed with the Fischer’s PLSD
test for post hoc multiple comparisons. The significance
limit was set at p = 0.05. For calculation, the StatView
5.0 software (SAS Institute Inc., Cary, NC, USA) was used.
Results
Gross observation
Postoperatively, all animals could put full weight on
their limbs without restriction of motion and limpingGroup I Group
Figure 2 In gross observation, the defects in Groups I and II were fille
III showed reddish patchy tissues.1 week after surgery. At the death of the animals, we
confirmed that there were no findings indicating infec-
tion of the knee joint, for example, swelling or purulent
discharge. In gross observation, we did not observe any
inflammatory findings or any pathological changes in
each knee joint at 12 weeks. The defects in Groups I
and II were filled with a white opaque elastic tissue,
while the defects in Group III showed reddish patchy
tissues (Figure 2). Concerning the Wayne’s score at
12 weeks, the ANOVA showed a significant difference
among the 3 groups (p < 0.0001) (Table 1). The post-hoc
test indicated that Group I was significantly greater than
Groups II and III (p = 0.0350 and p < 0.0001, respect-
ively), while Group II was significantly greater than
Group III (p = 0.0069) (Figure 3).
Histological and immunohistochemical observations
At 12 weeks, we did not observe any inflammatory find-
ings in the synovial tissue of each knee joint. The defect in
Group I was filled with a proteoglycan-rich tissue, while
the width of this tissue was approximately the same as that
of the normal articular cartilage (Figure 4A, D). In the
proteoglycan-rich tissue, type 2 collagen was abundantly
expressed (Figure 4G, p). In high magnification histology
of Group I, no cleft was observed between the regenerated
tissue and the normal cartilage tissue (Figure 4j). In the
regenerated tissue, fairly large round cells rich in cyto-
plasm were scattered singly or as an isogenous group in
a proteoglycan-rich matrix (Figure 4k, m). In Group II,
the defect was filled with thin heterogeneous tissues,
including cartilage, fibrous, and bone tissues at 12 weeks
(Figure 4B, E, l, n). The width of this tissue was approxi-
mately a half of the normal cartilage. In this tissue, type
2 collagen was not uniformly expressed (Figure 4H, q).
In this tissue, cells were rather small and sparse II Group III
d with a white opaque elastic tissue, while the defects in Group
Table 1 Gross appearance
Group I Group II Group III P value
Total score 13.2 (2.6)a, b 11.0 (2.2)b 8.1 (1.8) < 0.0001
Sub score
Coverage 3.7 (0.7)a, b 3.0 (0.5) 2.4 (0.8) 0.0009
Neocartilage color 3.1 (0.6)b 2.8 (0.6)b 2.2 (0.4) 0.0036
Defect margins 3.1 (0.6)b 2.8 (0.6)b 1.9 (0.7) 0.0009
Surface 3.3 (1.2)a, b 2.4 (0.7) 1.6 (0.7) 0.0008
aSignificantly different from Group II (P < 0.05).
bSignificantly different from Group III (P < 0.05).
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was completely absorbed. In Group III, the defect was
filled with the fibrous and bone tissues (Figure 4C, F, o),
while the type 2 collagen expression was not found in
this tissue (Figure 4I, r). Concerning the histological
scores at 12 weeks, the ANOVA showed a significant
difference among the 3 groups (p < 0.0001) (Table 2). The
post-hoc test indicated that Group I was significantly
greater than Groups II (p = 0.0104) and III (p < 0.0001),
while Group II was significantly greater than Group III
(p = 0.0050) (Figure 5). The cell density in the
proteoglycan-rich tissue was significantly higher in
Group I than in Groups II (p = 0.0001) and III (p < 0.0001),
and significantly higher in Group II than in Group III
(p < 0.0001) (Table 3).
Real-time PCR analysis
The real time PCR analysis showed that gene expression
of type-2 collagen and aggrecan of Group I was 5 times




















Figure 3 Concerning the Wayne’s score on gross obsevation at
12 weeks, the ANOVA showed a significant difference among
the 3 groups (p < 0.0001). The post-hoc test indicated that Group I
was significantly greater than Groups II and III, while Group II was
significantly greater than Group III.(Figure 6). SOX9 was highly expressed in both Groups I
and II to the same degree.
Discussion
The present study showed, first, that the OP1-SCS disc
did not show any detrimental effects in the knee joint,
when they were implanted into an osteochondral defect
created in the rabbit knee. These results showed that the
fish-derived collagen sponge-OP-1complex can be used
as a safe implant material from the viewpoint of the im-
munological reaction. Secondly, this study indicated that
the implanted OP1-SCS disc was completely absorbed at
12 weeks. This result was supported by our previous
study that the absorption rate of the crosslinked SC
sponge was significantly higher than the crosslinked
porcine collagen sponge [12]. The excellent absorbability
is considered to be one of advantages of this implant-
ation device for cartilage repair. Thirdly, the quantita-
tive comparisons in this study showed that the Wayne’s
score of Group I was significantly higher than that of
Groups II and III. In addition, gene expression of type-2
collagen and aggrecan of Group I was 5 times and 3
times, respectively, as much as that of Group II. The
fact that SOX9 was highly expressed in both Groups I
and II to the same degree may be explained by the find-
ings that chondrocyte differentiation was induced in
both the 2 groups. Thus, the present study clearly dem-
onstrated that the implantation of the OP1-SCS disc
without any cultured cells may induce spontaneous
hyaline-like cartilage regeneration to greater degrees
than implantation of only the salmon-derived collagen
sponge disc.
There are a few differences between the salmon-
derived and mammalian-derived collagens: First, the hy-
droxyproline content of the salmon-derived collagen is
about half of that of the porcine collagen [10]. The low
content of hydroxyl group in the salmon-derived colla-
gen leads to a higher hydrophobicity of salmon-derived
collagen than that of porcine collagen. Secondly, man-
ner of integrin-mediated cell attachment to a collagen
peptide is different between the salmon-derived colla-
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Figure 4 Histological observations of the defect at 12 weeks (A-C: Hematoxylin-Eosin staining, D-F: Safranin-O staining, G-I: immuno-
histological staining for type II collagen, original magnification ×2). Group I was filled with a proteoglycan-rich tissue, in which type 2
collagen was abundantly expressed (A, D, and G). In high magnification histology of Group I, no cleft was observed between the regenerated
tissue and the normal cartilage tissue (j: A black bar shows 200 micrometer). In the regenerated tissue, fairly large round cells rich in cytoplasm
were scattered singly or as an isogenous group in a proteoglycan-rich matrix (k, l, p). In Group II, the defect was filled with thin heterogeneous
tissues, including cartilage, fibrous, and bone tissues at 12 weeks (B and E). In this tissue, type 2 collagen was not uniformly expressed (H, q). In
this tissue, cells were rather small and sparse (m, n). In Group III, the defect was filled with the fibrous and bone tissues (Figure C and F), while
the type 2 collagen expression was not found in this tissue (I, r).
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attachment to the salmon-derived collagen gel depends
on the alpha v beta 3 integrins as well as the alpha 2
beta 1 integrin, while the human umbilical vein endo-
thelial cell attachment to the bovine collagen gel
depends on the alpha 2 beta 1 integrin. Integrins notonly mediate cell adhesion to the extracellular matrix
but also activate intracellular signaling pathways [20].
It was noted that implantation of only the salmon-
derived crosslinked collagen sponge disc had a mild but
significant effect that induced hyaline-like cartilage
regeneration in an osteochondral defect at 12 weeks in
Table 2 Histology
Group I Group II Group III P value
Total score 14.1 (4.0)a, b 10.4 (2.6)b 6.3 (2.1) < 0.0001
Sub score
Matrix 2.7 (1.3)b 1.9 (0.6)b 0.9 (0.6) 0.0006
Cell distribution 2.4 (0.5)b 1.9 (0.9) 1.4 (0.5) 0.0082
Surface 3.6 (0.7)a, b 2.6 (0.8)b 1.8 (0.4) < 0.0001
Safranin at O stain 2.7 (0.9)b 2.1 (0.9)b 1.1 (0.6) 0.0006
Percent Safranin O in defect 2.7 (1.1)a, b 1.9 (0.9)b 1.1 (0.6) 0.0012
aSignificantly different from Group II (P < 0.05).
bSignificantly different from Group III (P < 0.05).
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speculate possible reasons to explain this phenomenon.
First, in the patellofemoral joint, immediate motion and
loading results in high shear forces, preventing the for-
mation of an blood clot and might also be the reason for
poor cartilage regeneration. Therefore, first, the function
of this cell-free scaffold is to provide a temporary struc-
ture while cells seeded within the biodegradable matrix
synthesize hyaline-like cartilage tissue. Secondly, the
salmon-derived collagen appears to have higher bio-
logical functions than the mammalian-derived collagen
[12]. For example, it is reported that human periodontal
ligament fibroblasts showed better growth and higher
alkaline phosphatase activity in culture on the salmon-
derived collagen than in the culture with the porcine
collagen [10]. Thirdly, there is a possibility that an
increase of the degree of crosslinking in the the salmon-























Figure 5 The histological scores at 12 weeks. The ANOVA
showed a significant difference among the 3 groups (p < 0.0001).
The post-hoc test indicated that Group I was significantly greater
than Groups II and III, while Group II was significantly greater than
Group III.effect of hyaline-like cartilage regeneration [12]. There
are a few reports that the crosslinking of collagen
molecules enhanced the DNA synthesis of epidermal
cells [20] and the proliferation of endothelial cells [21].
In the salmon-derived atelocollagen disc used in the
present study, the degree of reduction of the free-amino
residues was about 20% [9]. The reduction of free-amino
residues changes the chemical properties of the salmon-
derived atelocollagen [9]. In addition, crosslinking changes
the mechanical properties of the collagen sponges. It is
known that the mechanical properties of the scaffold affect
the cellular functions and morphologies [22]. Thus, we
consider that these mechanisms may enhance the ability
of the salmon-derived collagen, which induces hyaline-like
cartilage regeneration. However, further biological and
biomechanical studies are needed to clarify how the
above-described differences in the collagen sponges affect
the cartilage regeneration.
We considered the mechanism of the effect of OP-1.
Previous in vitro studies showed that OP-1 up-regulates
chondrocyte metabolism and enhances protein and pro-
teoglycan synthesis in chondrocytes [23-27], Also recent
studies have shown that OP-1 stimulates cartilage-
specific extracellular proteins, such as type II and VI
collagens, aggrecan, decorin, fibronectin, hyaluronan,
and so on, in chondrocytes [16,28]. Furthermore, OP-1
has anti-catabolic activities for chondrocytes. Namely,
OP-1 effectively counteracts chondrocyte catabolism
induced by various catabolic mediators, such as
proinflammatory cytokines and fragments of cartilage
matrix proteins [29,30]. OP-1 also modulates the expres-
sion of various catabolic mediators [31]. Therefore, there is
a possibility that the OP-1 might affect the chondrocytes,
which were differentiated from mesenchymal stem cells by
existence of the salmon-derived crosslinked collagen
sponge, as shown in our previous study [12]. In addition,
several in vivo studies reported that OP-1 itself promotes
chondrogenic differentiation and matrix formation [32-34].
Therefore, there is also a possibility that the applied OP-1
additionally promoted chondrogenic differentiation of the
mesenchymal stem cells which migrated into the sponge,
Table 3 Cell density
Group I Group II Group III P value
Cell density Per mm2 592.7 (130.0)a,b 280.7 (104.1)b 0 (0) < 0.0001
aSignificantly different from Group II (P < 0.05).
bSignificantly different from Group III (P < 0.05).
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proteins and proteoglycans.
There are some limitations in this study. The first
limitation is that we did not perform long-term obser-
vation of the regenerated cartilage. A long-term evalu-
ation study is needed to be performed immediately after
this study. The second limitation is that we did not per-
form statistical analysis concerning the gene expression
of type-2 collagen, aggrecan, and SOX9 for the insuffi-
cient number of specimen. In addition, we did not
evaluate the gene expression of type-1, and −10 colla-
gen. Thirdly, we did not perform a biochemical and bio-
mechanical analyses of the regenerated cartilage.
Fourthly, we did not perform both in vitro and in vivo
studies on the release/production of OP-1 from the
sponge. However, Hayashi et al. [35] demonstrated that
the cartilage was obtained from rabbit knee joints at
1 hour and 1, 2, 4, and 7 days after intra-articular injec-
tion of 500 ng OP-1. 1 hour after BMP-7 injection,
BMP-7 was detected at high levels in cartilage; the level
decreased by 60% 1 day after injection. BMP-7 levels grad-
ually decreased over time, and 7 days after the last injec-
tion BMP-7 concentration in treated knees was still higher
than that in control knees. Therefore, we speculated that
in the present study there was the similar condition on the
elution of the factors from the sponge. Fifthly, we could
not determine the mechanism of the in vivo cartilage re-
generation induced by the the OP1-SCS disc in the
present experiment. The sixth limitation is that we im-
planted the sponge into the patellofemoral joint because
this joint is commonly used in animal studies to develop a
new treatment for a cartilage defect. Therefore, we cannot

































Figure 6 Real-time PCR analysis on gene expression of type-2 collage
collagen (A) and aggrecan (B) of Group I was 5 times and 3 times, res
expressed in both Groups I and II to the same degree.cartilage into the tibiofemoral joint. At the present time,
however, it is important to increase the database
concerning in vivo effects of cell-free devices for cartilage
regeneration. From this viewpoint, we believe that this
study is of value to propose a therapeutic concept using a
novel salmon-derived collagen device.
As to clinical relevance, this study implied that the
OP1-SCS disc is a promising cell-free device for cartilage
repair. This disc has great advantages including no risk
of zoonosis transmission, a quickly absorbable device, a
large source for commercial production with a low cost.
In addition, it is known that an application of OP-1 has
been clinically tried to treat nonunion of the fracture
and massive bone and to promote spine fusion in the
field of orthopaedic surgery [36,37]. Therefore, the safty
of OP-1 has been established for clinical use. We believe
that the OP1-SCS disc is of value to be studied more as
a potential therapeutic device for cartilage repair in the
near future. For example, further long-term studies
using large animals are needed to establish the efficacy
(proof of concept) of this device.Conclusion
The present study showed that the histological score of
Group I was significantly higher than that of Groups II
and III. In addition, gene expression of type-2 collagen
and aggrecan of Group I was greater than that of Group
II. Thus, the present study clearly demonstrated that the
implantation of the OP1-SCS disc without any cultured
cells may induce spontaneous hyaline-like cartilage
regeneration to greater degrees than implantation of
only the salmon-derived collagen sponge disc.C

















n, aggrecan, and SOX9 at 12 weeks. mRNA expression of type-2
pectively, as much as that of Group II. SOX9 (C) was highly
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